Insurance Adjuster Negotiation Playbook for Pharmacy Liens
James Wong — Founder & CEO, LienScripts | March 29, 2026 | 8 min read
A step-by-step negotiation playbook for PI attorneys facing insurance adjuster challenges to pharmacy lien balances. Covers the most common tactics, scripted responses, and documentation strategies that protect lien value through settlement.
Insurance Adjuster Negotiation Playbook for Pharmacy Liens
Insurance adjuster challenges to pharmacy liens follow predictable patterns that PI attorneys can anticipate, prepare for, and counter with clinical documentation and legal authority. This playbook provides specific responses to the most common adjuster tactics encountered during settlement negotiations involving pharmacy lien balances.
- A pharmacy lien negotiation playbook arms PI attorneys with scripted rebuttals for the six most frequent adjuster challenges
- LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages
- Each adjuster tactic has a documented counter-strategy grounded in clinical evidence, legal precedent, and pharmacy records
- Proactive documentation before negotiation eliminates most adjuster leverage
- According to James Wong, PharmD, founder of LienScripts, attorneys who prepare pharmacy lien defenses before the first adjuster call resolve cases faster and at higher values
Tactic #1: "These Medications Were Available Through Insurance"
Adjusters frequently argue that the plaintiff could have obtained medications through existing health insurance rather than a pharmacy lien, implying the lien balance is unnecessary.
Your Response:
The availability of health insurance does not make a pharmacy lien inappropriate. Health insurers routinely deny accident-related prescriptions under coordination-of-benefits clauses. Even when coverage exists, formulary restrictions, prior authorization delays, and high out-of-pocket costs create real access barriers for injured plaintiffs who are often unable to work.
Additionally, using health insurance creates a subrogation interest that must be satisfied at settlement. Routing medications through a pharmacy lien captures the full cost as special damages, often producing a higher net recovery for the client than triggering health insurance subrogation.
[!KEY] When an adjuster raises the insurance availability argument, ask them to identify which specific medications on the lien were covered by the plaintiff's formulary without prior authorization. This shifts the burden from a general assertion to a factual claim they rarely can support.
Tactic #2: "The Treatment Duration Is Excessive"
Adjusters challenge the length of medication therapy, arguing that prescriptions extending beyond a certain period indicate over-treatment or malingering.
Your Response:
Treatment duration is a clinical decision made by the prescribing physician based on the patient's ongoing symptoms and response to therapy. Musculoskeletal injuries, neuropathic pain conditions, and post-traumatic migraine frequently require medication courses measured in months, not weeks.
The LienScripts MERIT report documents the clinical rationale for treatment duration, tying each prescription refill to documented physician assessments. A prescription that continues for six months because the treating physician documents ongoing radiculopathy at each follow-up visit is not excessive treatment — it is appropriate care for a persistent injury.
Tactic #3: "Brand Medications Should Be Reduced to Generic Pricing"
This is among the most common adjuster positions. The argument assumes that all brand medications have clinically equivalent generic alternatives.
Your Response:
Many brand medications prescribed in PI cases — including CGRP antagonists like Qulipta, Nav1.8 inhibitors like Journavx, and specific compound formulations — have no generic equivalent. They represent distinct pharmacological mechanisms that generics do not replicate.
For medications that do have generic equivalents, the prescribing physician's decision to use the brand formulation is a clinical judgment. Challenging that judgment requires a competing medical opinion, not an adjuster's unilateral assertion.
[!TIP] Include a one-page medication summary from LienScripts in your demand package that identifies which medications on the lien have no generic equivalent and which were prescribed as brand for documented clinical reasons. This preempts the generic pricing argument before it is raised.
Tactic #4: "The Number of Medications Indicates Over-Treatment"
Adjusters see a lien with five or six medications and characterize it as billing maximization rather than clinical necessity.
Your Response:
Multi-system injuries require multi-mechanism treatment. A patient with lumbar disc herniation, cervical strain, post-traumatic migraine, and anxiety following a motor vehicle accident may appropriately take a neuropathic pain agent, a muscle relaxant, a migraine-specific medication, an anti-inflammatory, and an anxiolytic. Each addresses a different injury component through a different pharmacological mechanism.
As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "The number of medications on a lien directly reflects the number of body systems injured. A five-medication lien for a five-system injury is not polypharmacy — it is targeted treatment."
Tactic #5: "The Pharmacy Charges Exceed Usual and Customary Rates"
Adjusters argue that lien-based pharmacy pricing exceeds what insurance or cash-pay patients would pay for the same medications.
Your Response:
Pharmacy lien pricing reflects risk-adjusted compensation. The pharmacy dispenses medications with no upfront payment and assumes the risk that the case may not settle or that the settlement may be insufficient to satisfy the lien in full. This risk premium is analogous to attorney contingency fee structures, where the effective hourly rate exceeds flat-fee rates precisely because of non-payment risk.
The legal standard for damages is reasonable value — not insurance reimbursement rates. Insurance rates reflect negotiated network discounts that are contractual, not market-based. Reasonable value in the PI context is a factual question based on the market for risk-adjusted pharmacy services.
Tactic #6: "Causation — These Medications Are for Pre-Existing Conditions"
The adjuster argues that some or all medications on the lien were for conditions that pre-dated the accident.
Your Response:
Prescriptions initiated after the accident date, prescribed by treating physicians who documented accident-related diagnoses, are presumptively related to the accident. The defense bears the burden of proving that a specific prescription was for a pre-existing condition rather than an accident-related injury.
The eggshell plaintiff doctrine applies: if the accident aggravated a pre-existing condition, the defendant is liable for the full extent of the aggravation. A patient whose pre-existing mild arthritis was asymptomatic before the accident but required daily medication afterward has accident-caused damages.
[!KEY] The LienScripts MERIT report explicitly ties each medication to accident-related diagnoses documented in the treating physician's records, creating a prescription-by-prescription causation chain that adjusters must overcome with competing evidence rather than general assertions.
Building Your Pre-Negotiation File
Before the first adjuster call, assemble these documents:
- MERIT report from LienScripts — medical necessity and causation documentation for every medication
- Prescription timeline — showing each medication start date relative to the accident date
- Physician records — visit notes documenting symptoms and clinical assessments at each prescription date
- Formulary analysis — identifying which medications lack generic equivalents
- Subrogation calculation — showing why the lien route produces higher net recovery than health insurance routing
This documentation package addresses all six adjuster tactics before they are raised, shifting the negotiation from defensive responses to proactive case presentation.
Contact LienScripts to discuss how pharmacy lien documentation strengthens your settlement negotiations.
Related Resources
- Top Adjuster Attacks on Pharmacy Liens — And How to Rebut Them
- How to Use Pharmacy Records in Your Demand Package
- Pharmacy Services for Personal Injury Clients: How It Works
Frequently Asked Questions
What is the most common adjuster challenge to pharmacy liens?
The most common challenge is the insurance availability argument — that the plaintiff should have used health insurance instead of a pharmacy lien. The counter is that health insurers often deny accident-related claims, formulary restrictions limit access, and using insurance triggers subrogation that reduces net recovery.
How should I prepare for pharmacy lien negotiations with adjusters?
Assemble a pre-negotiation file including the MERIT report from LienScripts, a prescription timeline showing medication start dates relative to the accident, treating physician records, a formulary analysis identifying medications without generic equivalents, and a subrogation comparison showing net recovery differences.
Can an adjuster unilaterally reduce pharmacy lien amounts?
No. Adjusters can assert negotiating positions, but they cannot unilaterally reduce lien amounts. The reasonableness of pharmacy lien pricing is a legal and factual question — not an adjuster determination. Pharmacy lien pricing reflects risk-adjusted compensation for dispensing without upfront payment.